Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
1h
on MSN
Gilead upgraded to outperform by Leerink on PreEP outlook
Leerink has upgraded Gilead Sciences (NASDAQ:GILD) to outperform, citing the growth outlook for its PrEP treatment ...
pharmaphorum
5h
Gilead, MSD say HIV combo could be weekly, oral HIV drug
Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...
Star Observer
8h
Douches, Long-Acting Jabs, Implants – All The New HIV Prevention Products Coming Our Way
From an anal PrEP douche to the first women-controlled HIV prevention product, here's all the new HIV prevention products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Liberty win first WNBA title
NYC subway death trial
Helicopter hits radio tower
WWII code talker dies
Faces new lawsuits
Gold hits fresh high
The Vessel to reopen
Ceasefire talks in Beirut
Advance to World Series
Albany State shooting
American activist Wair dies
To roll out AI agents in Nov
Hezbollah assets targeted
Oscar makes landfall
Blinken's Middle East trip
New Mexico flash flooding
Wins third PGA Tour title
Launches OneWeb mission
Baldwin returns to 'SNL'
Opens up on Russian camp
Oakland fire burns homes
Postpones US tour
Urges support for Ukraine
Orionids meteor shower
Rock & Roll HOF '24 class
CVS workers strike
Ferry dock collapses in GA
US probing documents leak
Related topics
islatravir
HIV
Gilead Sciences
Feedback